Erratum
The original article [1] contains an omission of information in the Financial support sub-section of the Declarations section.
The authors would like to acknowledge the Andrew McDonough B+ Foundation for financial support of co-author Dr Yi-Cheng Wang throughout this study, and regret this inadvertent omission from the original publication.
Footnotes
The online version of the original article can be found under doi:10.1186/s13045-015-0215-4.
Reference
- 1.Laszlo GS, et al. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group. J Hematol Oncol. 2015;8:115. doi: 10.1186/s13045-015-0215-4. [DOI] [PMC free article] [PubMed] [Google Scholar]